SCHEMBL3734760

SCHEMBL3734760

NC(N)(O)C(N)(N)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8907379 0.80
SCHEMBL278341 0.77
SCHEMBL63557 0.77
SCHEMBL9326718 0.77
SCHEMBL15321998 0.77 MEN1 (0.33)
SCHEMBL2462056 0.72
Hydrochloric Acid SCHEMBL1367308 0.71
Methane SCHEMBL10426222 0.71
SCHEMBL125130 0.71
SCHEMBL24134604 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100086678-A1 BRANCHED END REACTANTS AND POLYMERIC HYDROGEL TISSUE ADHESIVES THEREFROM E.I.DUPONT DE NEMOURS AND COMPANY (DE) 2010-04-08 US claimed
WO-2008098213-A9 PURE POLYUREA AND METHOD FOR MAKING SAME REACTAMINE TECHNOLOGY LLC (US) 2008-12-24 WO disclosed
WO-2008098213-A2 PURE POLYUREA AND METHOD FOR MAKING SAME REACTAMINE TECHNOLOGY, LLC (US) 2008-08-14 WO disclosed
WO-2008086343-A2 SILICONE MODIFIED POLYUREA REACTAMINE TECHNOLOGY, LLC (US) 2008-07-17 WO disclosed
US-20080008866-A1 Silicone modified polyurea REACTAMINE TECHNOLOGY, LLC 2008-01-10 US disclosed
US-20070270240-A1 Pure polyurea and method for making same REACTAMINE TECHNOLOGY, LLC 2007-11-22 US disclosed
WO-2007120759-A2 SILICONE MODIFIED POLYUREA REACTAMINE TECHNOLOGY, LLC (US) 2007-10-25 WO disclosed
US-20060189778-A1 Silicone modified polyurea REACTAMINE TECHNOLOGY, LLC (US) 2006-08-24 US disclosed
EP-1352072-A4 NUCLEIC ACID DELIVERY FORMULATIONS ZYCOS INC (US) 2004-09-01 EP disclosed
US-20040147466-A1 Nucleic acid delivery formulations MGI PHARMA BIOLOGICS, INC. 2004-07-29 US disclosed
EP-1352072-A2 NUCLEIC ACID DELIVERY FORMULATIONS Zycos Inc. (US) 2003-10-15 EP disclosed
WO-2002057424-A2 NUCLEIC ACID DELIVERY FORMULATIONS ZYCOS INC. (US) 2002-07-25 WO disclosed